## Clinical Scenario & Biochemical Mechanism This case illustrates a critical iatrogenic complication: **thiamine depletion during treatment of diabetic ketoacidosis (DKA)**, leading to secondary **pyruvate dehydrogenase (PDH) complex dysfunction** and recurrent lactic acidosis. ### The Pathophysiology of Recurrent Lactic Acidosis **Key Point:** Pyruvate dehydrogenase complex is a thiamine pyrophosphate (TPP)-dependent enzyme. Aggressive insulin therapy in DKA causes rapid glucose uptake and glycolysis, which depletes cellular thiamine stores. This impairs PDH function, blocking pyruvate oxidation and forcing it toward lactate production. #### Why PDH is the Answer 1. **Thiamine requirement**: PDH complex contains three enzymes (E1, E2, E3), and the E1 subunit (pyruvate dehydrogenase) absolutely requires **thiamine pyrophosphate (TPP)** as a cofactor. 2. **Mechanism of depletion**: - Insulin therapy drives glucose into cells → accelerated glycolysis → pyruvate production. - Glycolysis consumes thiamine-dependent enzymes (transketolase, pyruvate dehydrogenase). - Thiamine stores (limited in malnourished/diabetic patients) become depleted. 3. **Result**: Pyruvate cannot be oxidized to acetyl-CoA → accumulates → shunted to lactate → **lactic acidosis** (lactate 6.8 mmol/L, normal <2). 4. **Why ketones normalized**: Initial DKA was resolved by insulin; the recurrent acidosis is now lactate-driven, not ketone-driven. ### Pathophysiologic Timeline ```mermaid flowchart TD A[DKA: High glucose, high ketones]:::urgent --> B[Insulin therapy initiated]:::action B --> C[Rapid glucose uptake & glycolysis]:::action C --> D[Thiamine consumption accelerates]:::action D --> E[Thiamine stores depleted]:::urgent E --> F[PDH complex inactivated<br/>Loss of TPP cofactor]:::urgent F --> G[Pyruvate cannot → Acetyl-CoA]:::urgent G --> H[Pyruvate → Lactate via LDH]:::urgent H --> I[Recurrent Lactic Acidosis]:::urgent I --> J[pH 7.18, Lactate 6.8]:::outcome ``` ### High-Yield: Thiamine-Dependent Enzymes in Carbohydrate Metabolism | Enzyme | Cofactor | Substrate → Product | Affected in Thiamine Deficiency? | |--------|----------|---------------------|----------------------------------| | **Pyruvate dehydrogenase** | **TPP** | Pyruvate → Acetyl-CoA | **YES** | | **Transketolase** | **TPP** | Pentose phosphate pathway | **YES** | | **α-Ketoglutarate dehydrogenase** | **TPP** | α-KG → Succinyl-CoA | **YES** | | Citrate synthase | CoA | Acetyl-CoA + Oxaloacetate → Citrate | NO | | Fumarase | None (hydratase) | Fumarate ↔ Malate | NO | | Malate dehydrogenase | NAD⁺ | Malate ↔ Oxaloacetate | NO | **Clinical Pearl:** The triad of **recurrent lactic acidosis + DKA treatment + thiamine depletion** is pathognomonic for PDH dysfunction. This is a medical emergency requiring **immediate thiamine supplementation** (100 mg IV) *before* or *concurrent with* glucose administration. ### Clinical Management Implications **High-Yield:** In any patient with DKA or severe malnutrition receiving insulin: - Always give **thiamine 100 mg IV/IM before dextrose** (prevents Wernicke encephalopathy and PDH dysfunction). - Monitor lactate levels during insulin therapy; rising lactate despite correcting ketosis suggests thiamine depletion. - Thiamine repletion rapidly restores PDH function and resolves lactic acidosis. **Mnemonic: TPP Enzymes** — **T**ransketolase, **P**yruvate dehydrogenase, **P**hosphokinase (α-KG dehydrogenase) all require thiamine pyrophosphate. [cite:Harrison 21e Ch 436; Lehninger Principles of Biochemistry 7e Ch 20] 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.